Revolutionising Medicines Manufacturing Takes Serious Collaboration Feature session - Hosted by CPI

Time & Location

Wednesday: 11.00 to 12.00, Stage 3

Hosted by CPI

Terry ReedDirector of Business Development, AstraZeneca

About this Session

If partnering has crossed your mind when looking at ways to accelerate your innovation but don’t know where to start, come along to learn how CPI is leveraging the power of partnerships to overcome some of the challenges to successful collaboration.

Through a Grand Challenge model, aimed at tackling the pharmaceutical industry’s largest problems, CPI’s Medicines Manufacturing Innovation Centre is working together with collaborators in a pre-competitive environment, to break down barriers previously limiting the ability and speed of new and innovative technology adoption.

  • Session coordinator: Neil Sheddan, Business Development Director, Medicines Manufacturing Innovation Centre at CPI

Panellist Bio:

Panel discussion

Terry has worked in the pharmaceutical industry for over 15 years. He has specific responsibility for the enhancement of AstraZeneca’s Pharmaceutical Technology and Development capabilities, by enabling access to the best external science, technology, and innovation.

In AstraZeneca Terry has also been instrumental in introducing new technology and building capabilities across a number of domains and disciplines. Prior to joining AstraZeneca, Terry was Director of Global Commercial Development at Pharmagene. In all Terry has more than 25 years commercial experience in the life science sector, having also held business development and management positions at Oxford Gene Technology, De Novo Pharmaceuticals, Applied Biosystems, Amersham and Millipore.